HTA is multi-disciplinary field of policy analysis that examines the medical, economic, social and ethical implications of the incremental value, diffusion and use of a health technology in health care.
The term Health Technology refers to application of organised knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of life.
Prostate cancer (PCa) is the most common non-skin cancer in men in Europe. In early stage, prostate cancer is localised and organ-confined. Depend-ing on the risk of progression, the cancerous lesion increases in volume and produces more PSA over time. Localised prostate cancer is often indolent, and has no impact on health; even without treatment. Locally […]
Prostate cancer is the second most common cancer in men in Canada. It forms in the prostate gland of the male reproductive system and often grows very slowly. However, in some patients, prostate cancer grows more quickly and is fatal. One of the possible treatments for prostate cancer is to surgically remove the prostate gland. This […]
In Norway, breast cancer screening is offered through a publicly funded program to women in the age group 50-69 on a biennial basis. Breast cancer incidence is relatively higher among women in this age group than it is among younger women. The purpose of the screening program is to reduce breast cancer-related mortality by detecting tumors at an earlier stage. […]
Developments in diagnostic radiology have made it possible not only to perform increasingly precise scans and but also to reduce their associated radiation doses. Yet the growing use of these scans in medical practice and the advent of new technologies expose the population to an increasingly high collective dose. Computed tomography (CT) has been estimated to […]
MRI might improve diagnosis of breast cancer, reducing rates of reoperation. We assessed the clinical efficacy of contrast-enhanced MRI in women with primary breast cancer.We undertook an open, parallel group trial in 45 UK centres, with 1623 women aged 18 years or older withbiopsy-proven primary breast cancer who were scheduled for wide local excision after triple assessment. […]
A comprehensive evaluation of the BreastScreen Australia Program has been conducted, under the direction of the Australian Health Ministers Advisory Council (AHMAC) and managed by the Department of Health and Ageing. To inform this evaluation, the Department of Health and Ageing requested that the Health Policy Advisory Committee on Technology (Health PACT) undertake a Horizon Scan […]
Screening mammography, a technique which is 50 years old, aims to advance the diagnosis of breast cancer in order to offer early treatment, thereby improving the chances of cure. The practice of mammography, in constant evolution, varies widely according to the equipment used, the interpretation of films, and program aspects such as the age of women when they are […]